Balaban, E P <br/><br/>
Treatment of "poor risk" acute nonlymphocytic leukemia with continuously infused low-dose cytosine arabinoside.  [electronic resource] 

 -  American journal of hematology  Oct 1988 
 - 79-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0361-8609 
<br/><br/><label>Standard No.: </label>10.1002/ajh.2830290205  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Bone Marrow--pathology<br/>Cell Count<br/>Cytarabine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Karyotyping<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Prognosis<br/>Recurrence<br/>Remission Induction